1
|
Matuz A, Gács B, Birkás B. Reframing prolonged negative mental health effects of COVID-19: cognitive restructuring promotes posttraumatic growth. Psychol Health 2024:1-20. [PMID: 39545661 DOI: 10.1080/08870446.2024.2427654] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2024] [Revised: 09/22/2024] [Accepted: 11/03/2024] [Indexed: 11/17/2024]
Abstract
OBJECTIVE The study aimed to investigate the level of peritraumatic distress in relation to possible traumatic outcomes in university personnel and students across three pandemic waves. METHODS Three cross-sectional surveys were conducted to investigate university students and staff (n = 1426). An online survey including the COVID-19 Peritraumatic Distress Index (CPDI), Ways of Coping, Impact of Events Scale (IES), and Posttraumatic Growth Inventory (PTGI) were administered across three waves. Psychometric properties of the Hungarian version of CPDI were assessed and associations between peri/posttraumatic stress and coping were explored. Cluster analysis based on posttraumatic stress and growth was used to identify subgroups. RESULTS An increasing trend of peritraumatic stress over the waves was found. Regression analyses revealed that two coping styles, cognitive restructuring and problem analysis were negatively and positively associated, respectively, with both peritraumatic and posttraumatic stress. Two-step cluster analysis conducted on PTGI and IES scores yielded three clusters of posttraumatic changes: IES-low/PTGI-low, IES-high/PTGI-low and IES moderate/PTGI-high. Multinomial regression showed that cognitive restructuring and peritraumatic stress were significant predictors of cluster membership. CONCLUSION Our findings point out that cognitive restructuring may be effective for dealing with longer-term psychological results of traumatic life events, such as the COVID-19 pandemic, even in highly exposed groups of the society.
Collapse
Affiliation(s)
- András Matuz
- Department of Behavioural Sciences, Medical School, University of Pécs, Pécs, Hungary
- Szentágothai Research Centre, University of Pécs, Pécs, Hungary
| | - Boróka Gács
- Department of Behavioural Sciences, Medical School, University of Pécs, Pécs, Hungary
| | - Béla Birkás
- Department of Behavioural Sciences, Medical School, University of Pécs, Pécs, Hungary
| |
Collapse
|
2
|
Carmassi C, Bertelloni CA, Dell'Oste V, Pedrinelli V, Fantasia S, Atti AR, Goracci A, Nanni MG, Massimetti E, Dell'Osso L, Bui E. The relationship between peritraumatic distress, mental health symptoms, and functioning impairment in healthcare workers during the COVID-19 emergency. CNS Spectr 2024; 29:261-267. [PMID: 38327004 DOI: 10.1017/s1092852923006338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/09/2024]
Abstract
OBJECTIVE Healthcare workers (HCWs) were considered a population at risk for developing psychiatric symptoms during the COVID-19 pandemic, such as anxiety, depression, and post-traumatic stress disorder (PTSD). Peritraumatic distress is associated with post-traumatic psychopathological symptoms; however, little is known about how it may affect functioning. The study aimed at evaluating the level of peritraumatic distress in a sample of HCWs during the first wave of the COVID-19 pandemic and at examining the relationship between peritraumatic distress, mental health symptoms, and functioning impairment. METHODS A sample of 554 frontline HCWs were consecutively enrolled in major university hospitals and community services in Italy. The PDI, IES-R, PHQ-9, and GAD-7 were used to assess peritraumatic distress, symptoms of PTSD, depression, and anxiety, respectively, and the WSAS to investigate functioning impairment. PDI scores were higher among females, community services, physicians, and nurses. Furthermore, the PDI correlated significantly with the GAD-7, PHQ-9, IES-R, and WSAS. RESULTS In a mediation analysis, the direct effect of PDI on WSAS and the indirect effects through the PHQ-9 and IES-R were statistically significant (P < .001). CONCLUSION Peritraumatic distress reported by HCWs was associated with symptoms of PTSD, depression, and anxiety, but the association with reduced functioning may be only partially mediated through symptoms of depression and PTSD.
Collapse
Affiliation(s)
- Claudia Carmassi
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | | | - Valerio Dell'Oste
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - Virginia Pedrinelli
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - Sara Fantasia
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - Anna-Rita Atti
- Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy
| | - Arianna Goracci
- Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy
| | - Maria Giulia Nanni
- Department of Neurosciences and Rehabilitation, University of Ferrara, Ferrara, Italy
| | - Enrico Massimetti
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - Lilliana Dell'Osso
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - Eric Bui
- Department of Psychiatry Caen University of Caen, Normandy & Caen University Hospital, Caen, France
| |
Collapse
|
3
|
Miola A, Caiolo S, Pontoni G, Pozzan E, Moriglia C, Simionato F, Garofalo S, Perini G, Sambataro F. Anxiety and Depression during the Second Wave of the COVID-19 Pandemic: The Role of Coping Strategies. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023; 20:2974. [PMID: 36833670 PMCID: PMC9957361 DOI: 10.3390/ijerph20042974] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/09/2023] [Revised: 01/30/2023] [Accepted: 02/03/2023] [Indexed: 06/01/2023]
Abstract
BACKGROUND Evidence suggests increased anxious-depressive symptoms in the general population during the COVID-19 pandemic, also in its second wave. High symptom variability across individuals suggests that risk and protective factors, including coping strategies, can play a mediating role. METHODS General Anxiety Disorder-7, Patient Health Questionnaire-9, and Brief-COPE questionnaires were administered to people attending a COVID-19 point-of-care. Univariate and multivariate methods were used to test the association of symptoms with risk and protective factors. RESULTS A total of 3509 participants (27.5% with moderate-severe anxiety; 12% with depressive symptoms) were recruited. Sociodemographic and lifestyle factors, including age, sex, sleep, physical activity, psychiatric treatments, parenthood, employment, and religiosity were associated with affective symptoms. Avoidant (self-distraction, venting, behavioral disengagement) and approach (emotional support, self-blame but not positive reframing and acceptance) coping strategies predicted greater anxiety. Avoidant strategies, including venting, denial, behavioral disengagement, substance use, and self-blame, and the humor strategy were associated with more severe depressive symptoms, while the planning predicted the opposite. CONCLUSIONS Coping strategies, in addition to socio-demographic and life-habit factors, could have contributed to modulating anxious and depressive symptoms during the second-wave of the COVID-19 pandemic, thus advocating for interventions aimed at promoting positive coping strategies to reduce the psychosocial toll of the pandemic.
Collapse
Affiliation(s)
- Alessandro Miola
- Department of Neuroscience (DNS), Padua Neuroscience Center, University of Padova, 35127 Padua, Italy
- Medicine Faculty, University of Padova, 35127 Padua, Italy
- Casa di Cura Parco dei Tigli, 35037 Teolo, Italy
| | - Stefano Caiolo
- Medicine Faculty, University of Padova, 35127 Padua, Italy
- Psychiatry Section, Military Department of Forensic Medicine, 35137 Padua, Italy
| | - Giancarlo Pontoni
- Psychiatry Section, Psychophysiological Selection Office, Italian Army National Recruitment and Selection Center, 06034 Foligno, Italy
| | - Erica Pozzan
- Medicine Faculty, University of Padova, 35127 Padua, Italy
| | - Chiara Moriglia
- Psyops Development Center, 28th (APICE) Regiment “Pavia”, 61121 Pesaro, Italy
| | | | - Sergio Garofalo
- Psychiatry Section, Military Department of Forensic Medicine, 35137 Padua, Italy
| | - Giulia Perini
- Department of Neuroscience (DNS), Padua Neuroscience Center, University of Padova, 35127 Padua, Italy
- Medicine Faculty, University of Padova, 35127 Padua, Italy
- Casa di Cura Parco dei Tigli, 35037 Teolo, Italy
| | - Fabio Sambataro
- Department of Neuroscience (DNS), Padua Neuroscience Center, University of Padova, 35127 Padua, Italy
- Medicine Faculty, University of Padova, 35127 Padua, Italy
| |
Collapse
|
4
|
Cattarinussi G, Miola A, Trevisan N, Valeggia S, Tramarin E, Mucignat C, Morra F, Minerva M, Librizzi G, Bordin A, Causin F, Ottaviano G, Antonini A, Sambataro F, Manara R. Altered brain regional homogeneity is associated with depressive symptoms in COVID-19. J Affect Disord 2022; 313:36-42. [PMID: 35764231 PMCID: PMC9233546 DOI: 10.1016/j.jad.2022.06.061] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/09/2022] [Revised: 05/31/2022] [Accepted: 06/22/2022] [Indexed: 11/30/2022]
Abstract
BACKGROUND COVID-19 is an infectious disease that has spread worldwide in 2020, causing a severe pandemic. In addition to respiratory symptoms, neuropsychiatric manifestations are commonly observed, including chronic fatigue, depression, and anxiety. The neural correlates of neuropsychiatric symptoms in COVID-19 are still largely unknown. METHODS A total of 79 patients with COVID-19 (COV) and 17 healthy controls (HC) underwent 3 T functional magnetic resonance imaging at rest, as well as structural imaging. Regional homogeneity (ReHo) was calculated. We also measured depressive symptoms with the Patient Health Questionnaire (PHQ-9), anxiety using the General Anxiety Disorder 7-item scale, and fatigue with the Multidimension Fatigue Inventory. RESULTS In comparison with HC, COV showed significantly higher depressive scores. Moreover, COV presented reduced ReHo in the left angular gyrus, the right superior/middle temporal gyrus and the left inferior temporal gyrus, and higher ReHo in the right hippocampus. No differences in gray matter were detected in these areas. Furthermore, we observed a negative correlation between ReHo in the left angular gyrus and PHQ-9 scores and a trend toward a positive correlation between ReHo in the right hippocampus and PHQ-9 scores. LIMITATIONS Heterogeneity in the clinical presentation in COV, the different timing from the first positive molecular swab test to the MRI, and the cross-sectional design of the study limit the generalizability of our findings. CONCLUSIONS Our results suggest that COVID-19 infection may contribute to depressive symptoms via a modulation of local functional connectivity in cortico-limbic circuits.
Collapse
Affiliation(s)
- Giulia Cattarinussi
- Department of Neuroscience (DNS), University of Padova, Padua, Italy,Padua Neuroscience Center, University of Padova, Padua, Italy
| | - Alessandro Miola
- Department of Neuroscience (DNS), University of Padova, Padua, Italy,Padua Neuroscience Center, University of Padova, Padua, Italy
| | - Nicolò Trevisan
- Department of Neuroscience (DNS), University of Padova, Padua, Italy,Padua Neuroscience Center, University of Padova, Padua, Italy
| | - Silvia Valeggia
- Department of Medicine-DIMED, Radiology Institute, University of Padova, Azienda Ospedale-Università Padova, Padua, Italy
| | - Elena Tramarin
- Department of Medicine-DIMED, Radiology Institute, University of Padova, Azienda Ospedale-Università Padova, Padua, Italy
| | - Carla Mucignat
- Department of Molecular Medicine, University of Padova, Padua, Italy
| | - Francesco Morra
- Department of Medicine-DIMED, Radiology Institute, University of Padova, Azienda Ospedale-Università Padova, Padua, Italy
| | - Matteo Minerva
- Department of Medicine-DIMED, Radiology Institute, University of Padova, Azienda Ospedale-Università Padova, Padua, Italy
| | - Giovanni Librizzi
- Department of Medicine-DIMED, Radiology Institute, University of Padova, Azienda Ospedale-Università Padova, Padua, Italy
| | - Anna Bordin
- Department of Neurosciences, Otolaryngology Section University of Padova, Padua, Italy
| | - Francesco Causin
- Neuroradiology Unit, Neurosciences Department, University of Padova, Azienda Ospedale-Università Padova, Padua, Italy
| | - Giancarlo Ottaviano
- Department of Neurosciences, Otolaryngology Section University of Padova, Padua, Italy
| | - Angelo Antonini
- Padua Neuroscience Center, University of Padova, Padua, Italy,Parkinson and Movement Disorders Unit, Study Center for Neurodegeneration (CESNE), Department of Neurosciences, University of Padova, Padua, Italy
| | - Fabio Sambataro
- Department of Neuroscience (DNS), University of Padova, Padua, Italy; Padua Neuroscience Center, University of Padova, Padua, Italy.
| | - Renzo Manara
- Neuroradiology Unit, Neurosciences Department, University of Padova, Azienda Ospedale-Università Padova, Padua, Italy
| |
Collapse
|